- Home
- GOSS vs BFST Comparison
GOSS vs BFST Comparison
Compare GOSS & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOSS | BFST |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.8M | 739.5M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GOSS | BFST |
|---|---|---|
| Price | $3.45 | $26.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $8.60 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 2.8M | 115.7K |
| Earning Date | 11-05-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.25% |
| EPS Growth | N/A | ★ 11.95 |
| EPS | N/A | ★ 2.60 |
| Revenue | $44,051,000.00 | ★ $303,637,000.00 |
| Revenue This Year | N/A | $24.49 |
| Revenue Next Year | $6.41 | $17.06 |
| P/E Ratio | ★ N/A | $10.29 |
| Revenue Growth | N/A | ★ 21.51 |
| 52 Week Low | $0.71 | $20.07 |
| 52 Week High | $3.60 | $29.03 |
Technical Indicators
Market Signals| Indicator | GOSS | BFST |
|---|---|---|
| Relative Strength Index (RSI) | 64.60 | 64.55 |
| Support Level | $3.25 | $25.81 |
| Resistance Level | $3.45 | $27.03 |
| Average True Range (ATR) | 0.19 | 0.53 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 83.61 | 85.99 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.